A double-blind, placebo-controlled, randomized withdrawal, multicenter clinical trial will be evaluating the safety and efficacy of cariprazine in the treatment of Bipolar I disorder patients…
PSYCHIATRY
Jun 17, 2019
Cariprazine In A Dose-Reduction Paradigm In The Prevention Of Relapse In Bipolar I Disorder Patients
Jun 14, 2019
A new computational method will allow scientists to measure the effects of chronic inflammation on energy availability and effort-based decision-making. The method may yield insights into how…
Jun 13, 2019
UCSF resident physician Christopher M. Bartley, MD, PhD, explains how brain-targeted autoantibodies can cause neuropsychiatric symptoms in his 2019 Resident Trainee Research Award presentation.
Jun 12, 2019
Researchers at Portugal investigated vitamin D levels in affective and non-affective first-episode psychosis (FEP) in a medium latitude country (40° N) that provides significant sunlight exposure…
Jun 12, 2019
The 6th International Conference on Depression, Anxiety, and Stress Management scheduled during July 26-27, 2019 at Kyoto, Japan, is the leading meeting dedicated to Neurologist, Psychiatrists,…
Jun 10, 2019
The VA Connecticut Healthcare System is conducting a pilot randomized control trial to examine the initial efficacy of an established mindfulness intervention, Mindfulness Based Stress…
Jun 09, 2019
New research shows memories are pliable if you know which regions of the brain's hippocampus to stimulate, a finding that could someday enable personalized treatment for people with PTSD,…
Jun 07, 2019
Researchers conducted a systematic review and meta-analysis of the blood and cerebrospinal fluid (CSF) measures of the endocannabinoid system (ECS) in psychotic disorders. They found that testing…